Cardiovascular & metabolic disease
There are 55 results matching your search criteria
Clear all filters
FAIMS
Owlstone Medical Wins Contract from U.S. Department of Defense to Develop Handheld Breath Biopsy Device for Early Infectious Disease Detection
Gut & Digestion
Owlstone Medical Launches OMED Health to Enable Patients to Better Understand their Gut Microbiome and Manage their Digestive Health
Cancer
Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection
Breath Biopsy
Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection
Company Updates
Owlstone Medical Launches Breath Biopsy VOC Atlas
Company Updates
Owlstone Medical Appoints Mark Capone to Board of Directors
Breath Biopsy
Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy
COVID-19
Owlstone Medical Publishes Data on the Use of Face Mask Filters to Capture Viral Particles for SARS-CoV-2 Detection
Breath Biopsy
Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic
Breath Biopsy
Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases
Breath Biopsy
Owlstone Medical Announces Key Study Results on use of Breath Biopsy for Improved Detection of Liver Disease including NASH and NAFLD
